Research Articles

Bell RJ, Lijovic M, Fradkin P, Schwarz M, Davis SR. Changes in patterns of use of cigarettes and alcohol in women after first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia. Supportive Care Cancer 2012 20:783-789 [Epub 9th April 2011]

Panjari M, Bell RJ, Burney S, Bell S, McMurrick PJ, Davis SR. Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence. J Sex Med 2012 Nov;9(11):2749-58

O'Halloran T, Bell RJ, Robinson PJ, Davis SR. Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Inter Medicine 2012 Jul 17;157(2):87-93

Davis SR, Robinson PJ, Moufarege A, Bell RJ. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women. Clin Endorinol (Oxf). 2012 Oct;77(4):541-7

Panjari M, Bell RJ, Fradkin P, Davis SR. Cosmetic surgery prior to diagnosis of breast cancer. Climacteric 2012 Apr;15(2):195-9

Bell RJ, Robinson PJ, Fradkin P, Schwarz M, Davis SR. Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia. Breast 2012 Jun;21(3):394-400

Davis SR, Bell RJ, Wang Y, Hanna F, Davies-Tuck M, Bell R, Chirgwin J, Cicuttini F. Aromatase inhibitors associated with knee subchondral bone expansion without cartilage loss. Climacteric 2012 15:1-7 [Epub]

Panjari M, Davis SR, Fradkin P, Bell RJ. Breast cancer survivors' beliefs about the causes of breast cancer. Psychooncology 2012Jul;21(7):724-9

Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 2012 Feb; 131(3):949-55.

Review Articles

Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P; Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric 12 Oct;15(5):419-29

Fooladi E, Davis SR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother 2012 Oct;13(15):2131-42

Davis SR, Braunstein GD. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2012 2012 Apr;9(4):1134-48

Hickey M, Elliot J, Davison S. Hormone Replacement Therapy. BMJ 2012 Feb 16;344:e763. doi: 10.1136/bmj.e763.

Nappie RE, Davis SR. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 2012 Jun;15(3):267-74

Davis S. Can the severity of menopausal symptoms be predicted? BMJ 2012 Feb 8;344:d7664. doi: 10.1136/bmj.d7664

Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric 2012 Aug;15(4):306-16

Bell RJ, Burton RC. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? Med J Australia 2012 Jan 16;196(1):17

Worsley R, Davis SR, Gavrilidis E, Gibbs Z, Lee S, Burger H, Kulkarni J. Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas 2012 Oct;73(2):127-33


Jane F, Davis S, Bell R. A research participants rights as an ethical dilemma. Aust NZ J Public Health. 2012 36(6):508-510


Davis SR. Testosterone use in women. In: Testosterone, Deficiency, Substitution 4th Edition. Editors E Nieschlag, H M Behre, S Nieschlag. Cambridge University Press UK. 2012 Chapter 23 pages 494-516


Burton RC, Bell RJ. Letter in response: the value of mammography screening. Breast Cancer Res Treat 2012 Aug;134(3):1345-6

Bell RJ, Burton RC. Screening and breast cancer mortality-letter. Cancer Epidemiol Biomarkers Prev 2012 Dec;21(12):2275; author reply 2276-7